Preterm Infant

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Intact Umbilical Cord MilkingN/A1 trial
Active Trials
NCT03200301Active Not Recruiting250Est. Apr 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Mission TherapeuticsIntact Umbilical Cord Milking

Clinical Trials (1)

Total enrollment: 250 patients across 1 trials

NCT03200301Mission TherapeuticsIntact Umbilical Cord Milking

Effect of Intact Umbilical Cord Milking on Neonatal and First Year Neurodevelopmental Outcomes in Very Preterm Infants.

Start: Apr 2018Est. completion: Apr 2024250 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space